After suffering delay after delay, Novavax finally made it to the FDA back in January with its protein-based Covid-19 vaccine. But the Maryland-based company isn’t waiting for an authorization to get its name out there.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,